Insperity (NSP) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 Jul, 2026Executive summary
Q1 2026 Adjusted EPS was $1.31, down 17% year-over-year, while Adjusted EBITDA rose 1% to $103 million, both exceeding guidance midpoints.
Net income and diluted EPS both decreased 35% year-over-year to $33 million and $0.88, respectively, primarily due to a higher effective tax rate and margin recovery efforts.
Average paid worksite employees fell 1% to 303,049, at the low end of guidance, due to lower new client sales and higher attrition.
Margin recovery initiatives are ahead of schedule, with strategic focus on regaining growth momentum and leveraging AI and HRScale rollouts.
HRScale beta clients onboarded in March; nearly 6,000 worksite employees expected on HRScale within six months.
Financial highlights
Revenues rose 2% year-over-year to $1.9 billion, driven by a 3% increase in revenues per WSEE per month, offset by a 1% decline in average WSEEs paid.
Gross profit decreased 3% to $302 million, but margin recovery efforts showed progress versus a 21% decline in Q4 2025.
Gross profit per worksite employee was $332/month, slightly above forecast, aided by lower benefit costs.
Operating expenses decreased 1% to $240 million, including a $9 million restructuring charge; excluding this, expenses fell 5%.
Adjusted cash ended at $36 million, with $370 million in outstanding borrowings and $380 million in unused credit facility capacity.
Outlook and guidance
Full-year 2026 Adjusted EBITDA guidance remains $170–$230 million; Adjusted EPS guidance is $1.60–$2.60.
Worksite employee count forecast revised to 303,000–307,000, a 1%–2.3% decline from 2025.
Q2 2026 guidance: 302,500–304,500 worksite employees (down 1.5%–2.1% YoY), Adjusted EBITDA $18–$46 million, Adjusted EPS $0.02–$0.50.
Effective tax rate for Adjusted EPS expected at 36% for the year.
Adjusted operating expenses for 2026 expected to be about 5% below 2025, reflecting cost structure alignment.
Latest events from Insperity
- Solid Q4 results, resilient profitability, and Workday partnership set stage for 2025 growth.NSP
Q4 20249 Jul 2026 - Q2 2024 saw robust profit growth, but 2024 guidance was cut amid SMB market headwinds.NSP
Q2 20248 Jul 2026 - Proxy seeks approval for director elections, pay, equity plan amendment, and auditor ratification.NSP
Proxy filing14 Apr 2026 - 2026 guidance targets margin recovery and growth, led by HRScale and cost controls.NSP
Q4 202513 Feb 2026 - Q3 net income and EPS dropped sharply, with full-year adjusted EPS guided at $3.42–$3.66.NSP
Q3 202417 Jan 2026 - Higher healthcare costs and economic uncertainty drove lower Q1 earnings despite revenue growth.NSP
Q1 202524 Dec 2025 - Annual Meeting to vote on directors, pay, incentive plan amendment, and auditor ratification.NSP
Proxy Filing1 Dec 2025 - Q3 revenue up 4% but net loss and EBITDA fell on higher costs; 2026 recovery expected.NSP
Q3 202513 Nov 2025 - Higher benefits costs drove Q2 profit declines, but 2026 profitability outlook remains strong.NSP
Q2 202531 Oct 2025